We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cebranopadol as a Novel Promising Agent for the Treatment of Pain.
- Authors
Ziemichod, Wojciech; Kotlinska, Jolanta; Gibula-Tarlowska, Ewa; Karkoszka, Natalia; Kedzierska, Ewa
- Abstract
Opioids are used to treat pain, but despite their effectiveness, they possess several side effects such as respiratory depression, tolerance and physical dependence. Cebranopadol has been evaluated as a solution to this problem. The compound acts on the mu opioid receptor and the nociceptin/orphanin receptor and these receptors co-activation can reduce opioid side-effects without compromising analgesia. In the present review, we have compiled information on the effects of cebranopadol, its pharmacokinetics, and clinical trials involving cebranopadol, to further explore its promise in pain management.
- Subjects
PAIN management; NOCICEPTIN; RESPIRATORY insufficiency; OPIOID receptors; CLINICAL trials; PHARMACOKINETICS
- Publication
Molecules, 2022, Vol 27, Issue 13, p3987
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules27133987